0000921895-19-002465.txt : 20190927
0000921895-19-002465.hdr.sgml : 20190927
20190927171612
ACCESSION NUMBER: 0000921895-19-002465
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190918
FILED AS OF DATE: 20190927
DATE AS OF CHANGE: 20190927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ende Eric J
CENTRAL INDEX KEY: 0001494386
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23143
FILM NUMBER: 191122972
MAIL ADDRESS:
STREET 1: C/O MATINAS BIOPHARMA HOLDINGS, INC.
STREET 2: 1545 ROUTE 206 SOUTH, SUITE 302
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000835887
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133379479
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE WORLD TRADE CENTER
STREET 2: 47TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
BUSINESS PHONE: 646-975-2500
MAIL ADDRESS:
STREET 1: ONE WORLD TRADE CENTER
STREET 2: 47TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
3
1
form312274end_09272019.xml
OWNERSHIP DOCUMENT
X0206
3
2019-09-18
0
0000835887
PROGENICS PHARMACEUTICALS INC
PGNX
0001494386
Ende Eric J
6231 PGA BLVD., SUITE 104-168
PALM BEACH GARDENS
FL
33418
0
0
1
1
See Explanation of Responses
Common Stock, $0.0013 par value
0
D
The Reporting Person may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
/s/ Eric J. Ende
2019-09-27